Related Experiment Video

Updated: May 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

8.9K

Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancer

Tom Van Maerken1, Ali Rihani1, Alan Van Goethem1

  • 1Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Cancer Letters
|November 23, 2013
PubMed

Insights

Pediatric tumors often avoid TP53 (p53) mutations by inhibiting p53 activity. Nutlin drugs, which block the p53-MDM2 interaction, show promise for treating various childhood cancers by restoring p53 function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Childhood cancers rarely exhibit TP53 (p53) tumor suppressor gene mutations, unlike many adult tumors.
  • Pediatric tumors employ alternative mechanisms to inactivate p53, crucial for tumor cell survival.
  • The MDM2 oncoprotein is a key negative regulator of p53 activity.

Purpose of the Study:

  • To review preclinical data on nutlin drugs as potential therapeutics for pediatric cancers.
  • To highlight the role of MDM2-p53 interaction inhibitors in restoring wild-type p53 function.

Main Methods:

  • Review of preclinical studies on nutlin drugs.
  • Analysis of nutlin's efficacy in various pediatric tumor models.

Main Results:

  • Nutlin drugs selectively inhibit the p53-MDM2 interaction.
  • Preclinical data support the therapeutic potential of nutlins in diverse pediatric malignancies.
  • Nutlins offer a strategy to reactivate p53 in tumors with wild-type p53.

Conclusions:

  • Nutlin drugs represent a promising therapeutic strategy for pediatric cancers.
  • Targeting the p53-MDM2 interaction with nutlins could restore tumor suppressor function.
  • Further investigation into nutlin drugs for neuroblastoma, retinoblastoma, and other pediatric tumors is warranted.
Keywords:
MDM2NutlinPediatric tumorsTargeted therapyp53

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

400
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K